Intermittent immunoadsorption in critically ill patients with neuroimmunological disorders: a retrospective study
This study supports the feasibility and clinical utility of intermittent IA in critically ill patients with treatment-refractory neuroimmunological disorders. Despite frequent complications, flexible scheduling allowed continued therapy with sustained benefit. These findings highlight a potentially adaptable treatment strategy in a population often excluded from therapeutic interventions and suggest that IA warrants further study in neurocritical care settings.
Authors
- Shujuan Dai
- Jing Xu (ORCID: https://orcid.org/0000-0002-2758-5008)
- Lin Zhu (ORCID: https://orcid.org/0000-0002-6909-1655)
- Qian Wu (ORCID: https://orcid.org/0000-0002-6259-7434)
- Deshan Ge
Institutions
- Kunming Medical University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
- Third People's Hospital of Yunnan Province (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.3389/fneur.2025.1666042
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Kunming Medical University